TrialJournal of gynecologic oncology2024

Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.

Daisuke Aoki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.